Neuphoria Therapeutics Inc. Earnings Per Share (Basic)
Neuphoria Therapeutics Inc. (NEUP) reported Earnings Per Share (Basic) of -$3.06 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-18
- Neuphoria Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.91.
- Neuphoria Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.09, a 101.37% decline year-over-year.
- Neuphoria Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.41.
- Neuphoria Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$4.41.
- Neuphoria Therapeutics Inc. earnings per share, basic for fiscal 2026 was -$3.06.
- Neuphoria Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$0.23.
- Neuphoria Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$18.62.
- Neuphoria Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$0.02.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$3.06 10-K · filed 2026-09-18 | ||
| 2026-03-31 | -$0.09 10-Q · filed 2026-05-15 | $0.27 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.11 10-Q · filed 2026-05-15 | -$4.95 derived: net income ÷ weighted average shares · filed 2026-09-18 | ||
| 2025-12-31 | $0.41 10-Q · filed 2026-02-17 | -$2.37 10-Q · filed 2026-02-17 | -$5.85 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-09-18 | ||
| 2025-09-30 | -$4.41 10-Q · filed 2025-11-14 | -$9.06 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$3.85 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$5.09 derived: net income ÷ weighted average shares · filed 2026-09-18 | ||
| 2025-06-30 | -$4.67 derived: net income ÷ weighted average shares · filed 2026-09-18 | $1.31 derived: net income ÷ weighted average shares · filed 2026-09-18 | $0.25 derived: net income ÷ weighted average shares · filed 2026-09-18 | -$0.23 10-K · filed 2026-09-18 | ||
| 2025-03-31 | $6.55 10-Q · filed 2026-05-15 | $5.66 derived: net income ÷ weighted average shares · filed 2026-05-15 | $5.56 10-Q · filed 2026-05-15 | $4.32 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-12-31 | -$1.23 10-Q · filed 2026-02-17 | -$1.91 10-Q · filed 2026-02-17 | -$4.43 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$7.05 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-09-30 | -$0.62 10-Q · filed 2025-11-14 | $0.00 10-Q · filed 2024-11-14 | -$3.32 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$6.10 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$10.99 derived: net income ÷ weighted average shares · filed 2026-05-15 | |
| 2024-06-30 | -$3.35 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$6.13 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$11.39 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$18.62 10-K · filed 2025-09-29 | -$0.01 10-K · filed 2024-09-30 | |
| 2024-03-31 | -$2.83 10-Q · filed 2025-05-20 | -$7.98 derived: net income ÷ weighted average shares · filed 2025-05-20 | -$15.20 10-Q · filed 2025-05-20 | |||
| 2023-12-31 | -$5.31 10-Q · filed 2025-02-14 | -$12.96 10-Q · filed 2025-02-14 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$0.02 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |